🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Despite advances in obstetric care, preeclampsia (PE) remains the leading c...
Status
Recruiting
Location
Royal Victoria Hospital
Start Date
2021-07-12
Trial ID
NCT04783597
Treatments Being Tested
The goal of this clinical trial is to learn whether a structured lifestyle ...
Status
Not Yet Recruiting
Location
Yas Clinic
Start Date
2026-04-15
Trial ID
NCT07589062
Treatments Being Tested
This study is designed to determine the neural networks underlying the slee...
Status
Completed
Location
CH le Vinatier
Start Date
2015-12-09
Trial ID
NCT03130322
Sleep deprivation is common in intensive care. Impaired sleep quality and q...
Status
Completed
Location
University Rouen Hospital
Start Date
2022-12-16
Trial ID
NCT07167485
Treatments Being Tested
This randomized clinical trial aims to evaluate the impact of a structured ...
Status
Enrolling By Invitation
Location
Ellis Medicine/Roswell Park Medical Oncology
Start Date
2025-06-09
Trial ID
NCT06950190
Treatments Being Tested
Objectives: 1. Assess MAPS and MAPS+ effects on alcohol at-risk behaviors ...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2007-12
Trial ID
NCT00570804
Treatments Being Tested
Dysfunctional voiding is often associated with constipation. The associatio...
Status
Terminated
Location
Wake Forest University Health Sciences
Start Date
2009-09
Trial ID
NCT01003249
This is a prospective observational psychology study on a non-clinical popu...
Status
Recruiting
Location
Esquirol Hospital Center
Start Date
2025-04-01
Trial ID
NCT07072455
Treatments Being Tested
\--- Background and study aim Atrial fibrillation (AF) is an irregular hea...
Status
Active Not Recruiting
Location
University of Cambridge
Start Date
2023-02-02
Trial ID
NCT04715555
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percent...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-18
Trial ID
NCT03525678
Treatments Being Tested